Patents by Inventor Ryou-u Takahashi

Ryou-u Takahashi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8921333
    Abstract: The present invention provides a therapeutic agent for a tumor, particularly a therapeutic agent for drug-resistant cancer, an agent for suppression or prophylaxis of tumor metastasis, and an agent for suppression or prophylaxis of cancer recurrence, containing a nucleic acid containing miR27b or a nucleotide having a nucleotide sequence having an identity of 70% or more with the nucleotide sequence shown by SEQ ID NO: 1 and having a function equivalent to miR27b.
    Type: Grant
    Filed: October 1, 2010
    Date of Patent: December 30, 2014
    Assignees: National Cancer Center, Asahi Pharma Corporation
    Inventors: Takahiro Ochiya, Ryou-u Takahashi
  • Publication number: 20120252881
    Abstract: The present invention provides a therapeutic agent for a tumor, particularly a therapeutic agent for drug-resistant cancer, an agent for suppression or prophylaxis of tumor metastasis, and an agent for suppression or prophylaxis of cancer recurrence, containing a nucleic acid containing miR27b or a nucleotide having a nucleotide sequence having an identity of 70% or more with the nucleotide sequence shown by SEQ ID NO: 1 and having a function equivalent to miR27b.
    Type: Application
    Filed: October 1, 2010
    Publication date: October 4, 2012
    Applicants: ASAHI KASEI PHARMA CORPORATION, NATIONAL CANCER CENTER
    Inventors: Takahiro Ochiya, Ryou-u Takahashi
  • Publication number: 20090298955
    Abstract: An altered capsid protein of a primate-infective papovavirus in which a foreign peptide sandwiched by 1 to several glycine residues at each end is inserted into at least one of the DE-loop or the HI-loop of the capsid protein of the primate-infective papovavirus, and a virus-like particle formed from the altered capsid protein.
    Type: Application
    Filed: February 16, 2006
    Publication date: December 3, 2009
    Applicant: KONICA MINOLTA HOLDINGS, INC.
    Inventors: Hiroshi Handa, Akira Nakanishi, Shin-Nosuke Kanesashi, Ryou-u Takahashi